The Union Health Ministry made the largest allocation of hydroxychloroquine (HCQ) tablets since the onset of the COVID-19 epidemic in India by distributing 4.24 crore medicines to the states and union territories.
HCQ is an anti-malarial drug that is also used to treat other autoimmune diseases. Currently, this drug is being used for the treatment of COVID-19 patients and the virus is recommended as a prophylaxis according to the national workforce for COVID-19.
“Last Saturday, the government ordered the largest allocation for distribution of 4.24 crore HCQ drugs to the states and union territories for their use. This is the largest distribution ever since the onset of the virus epidemic. Using HCQ tablets. For the treatment of patients with COVID-19 and prophylaxis, “a senior Ministry of Health official said.
He said that the previous allocations were small and were done as per the requirement of the states. He also pointed out that the government has a large buffer stock of HCQ, and hence such allocations are being made.
According to the clinical management protocol for COVID-19, HCQ is described as “repurchase or label-therapy”. “It has also been noted that HCQ has demonstrated in vitro activity against SARS-CoV2 and has been shown clinically. Beneficial in many small single center studies, although with significant limitations.
Promote the latest songs only on JioSaavn.com
“This drug (HCQ) should be used as early in the course of the disease as possible to achieve any meaningful effect and should be avoided in patients with severe disease. The drug is prescribed to avoid QTK intervals (and HCQ) An ECG should ideally be performed before committing. If qcc> 500 ms). The dose should be given 400 mg twice a day and followed by 400mg daily for the next 4 days, “COVID-19 Clinical Management Protocol for.